Publications en collaboration avec des chercheurs de Imperial College London (5)

2019

  1. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628

2018

  1. Alirocumab and cardiovascular outcomes after acute coronary syndrome

    New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107

2012

  1. Immediate and late benefits of treating very elderly people with hypertension: Results from active treatment extension to hypertension in the very elderly randomised controlled trial

    BMJ (Online), Vol. 344, Núm. 7839

2010

  1. The effect of treatment based on a diuretic (indapamide) ± ACE inhibitor (perindopril) on fractures in the hypertension in the very elderly trial (HYVET)

    Age and Ageing, Vol. 39, Núm. 5, pp. 609-616

2003

  1. Results of the pilot study for the Hypertension in the Very Elderly Trial

    Journal of Hypertension, Vol. 21, Núm. 12, pp. 2409-2417